NCT05636046

Brief Summary

The goal of this observational study is to learn about the changing over the time of transseptal (TSP) catheterization for catheter ablation of arrhythmias in the left heart. This study aims to investigate if auxiliary tools for TSP catheterization improved the safety and efficacy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

10 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

November 20, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 5, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2024

Completed
Last Updated

December 5, 2022

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

November 20, 2022

Last Update Submit

December 1, 2022

Conditions

Keywords

Catheter ablationTransseptal catheterization

Outcome Measures

Primary Outcomes (2)

  • Adverse events related to inadvertent puncture cardiac structures other than atrial septum

    absence of adverse events related to transseptal catheterization

    Procedure time

  • Accomplishment of transseptal catheterization and electrophysiology procedure requiring transseptal catheterization

    accomplishment fo transseptal catheterization

    Procedure time

Study Arms (2)

transseptal catheterization performed without auxiliary tools

patients in whom transseptal catheterization have been performed without auxiliary tools

Procedure: transseptal catheterization

transseptal catheterization performed with auxiliary tools

patients in who transseptal catheterization have been performed with the use of auxiliary tools

Procedure: transseptal catheterization

Interventions

puncture of interatrial septum at the level of fossa ovalis, using transseptal needle.

Also known as: transseptal puncture
transseptal catheterization performed with auxiliary toolstransseptal catheterization performed without auxiliary tools

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients underwent trasseptal catheterization for catheter ablation of arrhythmias in the left heart

You may qualify if:

  • patients underwent transseptal catheterization of left side heart interventional procedures (catheter ablation)

You may not qualify if:

  • patients with learning disabilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Presidio Ospedaliero G. Salesi

Ancona, Italy

ENROLLING BY INVITATION

Ospedale Policlinico Sant'Orsola-Malpighi

Bologna, 40138, Italy

ENROLLING BY INVITATION

Spedali Civili di Brescia

Brescia, 25123, Italy

RECRUITING

Ospedale Desenzano del Garda

Desenzano del Garda, 25015, Italy

RECRUITING

Centro Cardiologico Monzino

Milan, 20138, Italy

ENROLLING BY INVITATION

Luigi Sacco University Hospital

Milan, 20157, Italy

RECRUITING

Ospedale San Raffaele

Milan, Italy

RECRUITING

Ospedale San Gerardo

Monza, 20900, Italy

RECRUITING

Ospedale Policlinico Universitario Agostino Gemelli

Roma, 00168, Italy

RECRUITING

Ospedale Di Circolo e Fondazione Macchi

Varese, 21100, Italy

RECRUITING

MeSH Terms

Conditions

Arrhythmias, CardiacHeart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Gianfranco Mitacchione, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator - Cardiac Electrophysiologist

Study Record Dates

First Submitted

November 20, 2022

First Posted

December 5, 2022

Study Start

November 20, 2022

Primary Completion

November 20, 2023

Study Completion

June 20, 2024

Last Updated

December 5, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations